Regulations.gov document
Supplement and Appendices from Boehringer Ingelheim Pharmaceuticals, Inc.
Supporting & Related Material · FDA-2012-P-1072 · posted Feb 2, 2021
Key facts
| Document ID | FDA-2012-P-1072-0005 |
|---|---|
| Title | Supplement and Appendices from Boehringer Ingelheim Pharmaceuticals, Inc. |
| Document type | Supporting & Related Material |
| Subtype | Electronic Regulation from Form |
| Agency | FDA |
| Docket | FDA-2012-P-1072 |
| Posted | Feb 2, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: